<DOC>
	<DOCNO>NCT00083018</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , nipple aspiration , ductal lavage , breast duct endoscopy , may help doctor detect assess breast cancer cell early plan effective treatment . PURPOSE : This phase II trial study well nipple aspiration , ductal lavage , duct endoscopy work assess cancer cell woman undergo surgery breast cancer .</brief_summary>
	<brief_title>Nipple Aspiration , Ductal Lavage , Duct Endoscopy For Diagnostic Assessment Women Undergoing Surgery Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Correlate cell yield morphology finding ductal lavage duct endoscopy finding surgical pathology finding woman breast cancer . - Determine sensitivity specificity nipple aspiration , ductal lavage , duct endoscopy detect establish breast cancer patient . Secondary - Compare intraduct environment cancer-involved duct affect breast v ductal system contralateral breast patient . - Perform immunohistochemical analysis ( include estrogen receptor , progesterone receptor , HER2-neu receptor , epidermal growth factor receptor , p53 , proliferation marker expression ) marker potentially associate breast cancer patient . - Determine potential molecular marker malignancy gene methylation , gene expression , proteomics patient . - Compare biochemistry protein analysis intraductal fluid v serum analysis patient . OUTLINE : Patients undergo nipple aspiration , ductal lavage , duct endoscopy general anesthesia immediately breast surgery . Fluid tissue obtain examined tumor marker immunohistochemistry . Candidate gene analyze gene methylation , gene expression array , proteomic profiling . Patients follow 24 hour 1 week . PROJECTED ACCRUAL : A total 100 patient accrue study within 1 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer No metastatic disease No inflammatory breast cancer Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 18 Sex Female Menopausal status Not specify Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No active infection inflammation breast study No known allergy eutectic mixture local anesthetic ( EMLAÂ® ) cream lidocaine No severe illness Not unconscious No mental illness handicap No nursing within past 12 month Not pregnant PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery No prior breast implantation side propose lavage No prior subareolar ( e.g. , papilloma resection , biopsy , fine needle aspiration ) surgery may disrupt ductal system within 2 cm nipple Biopsies fineneedle aspiration &gt; 2 cm nipple allow</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage IB breast cancer</keyword>
</DOC>